GPX4-targeting therapy reduces epigenetic age markers and circulating inflammation, raising questions about effects beyond treated skin.
Link as first comment.
@longevitytech.bsky.social
@longevitytech.bsky.social
@longevitytech.bsky.socialGPX4-targeting therapy reduces epigenetic age markers and circulating inflammation, raising questions about effects beyond treated skin.
Link as first comment.